Literature DB >> 23624761

Comparison of the abilities of the plasma triglyceride/high-density lipoprotein cholesterol ratio and the metabolic syndrome to identify insulin resistance.

Martin R Salazar1, Horacio A Carbajal, Walter G Espeche, Carlos E Leiva Sisnieguez, Carlos E March, Eduardo Balbín, Carlos A Dulbecco, Marcelo Aizpurúa, Alberto G Marillet, Gerald M Reaven.   

Abstract

This study compares the ability of an elevated triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio, using sex-specific cut-points, to identify insulin-resistant individuals within a population without known cardiac disease or diabetes with that obtained using the diagnostic criteria of the metabolic syndrome (MetS). Measurements were made of waist circumference (WC), systolic and diastolic blood pressure, fasting plasma glucose, fasting plasma insulin (FPI), plasma TG and plasma HDL-C concentrations in 1102 women and 464 men. These data were used to classify subjects as being insulin resistant (FPI concentration in the upper quartile) and having the MetS or an elevated TG/HDL-C ratio (>2.5 and >3.5 for women and men, respectively). The sensitivity and specificity with which the two indices identified insulin-resistant subjects were similar (43% and 81% for TG/HDL-C ratio and 45% and 82% for MetS), as the number of individuals was found with either an elevated TG/HDL-C ratio (n = 386) or the MetS (n = 384). Eighty-one per cent of the individuals were identified concordantly. Cardio-metabolic risk profiles in 'low-risk' individuals identified by a low TG/HDL-C ratio were comparable to those who did not have the MetS, and this was also the case when comparing 'high-risk' groups identified by having the MetS or an elevated TG/HDL-C ratio. These findings suggest that TG/HDL-C concentration ratio is as adequate as MetS diagnosis to identify insulin-resistant subjects.

Entities:  

Keywords:  cardio-metabolic risk; insulin resistance; metabolic syndrome; triglyceride/high-density lipoprotein cholesterol ratio

Mesh:

Substances:

Year:  2013        PMID: 23624761      PMCID: PMC5858929          DOI: 10.1177/1479164113479809

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  27 in total

1.  Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.

Authors:  Giovanni Musso; Roberto Gambino; Simona Bo; Barbara Uberti; Giampaolo Biroli; Gianfranco Pagano; Maurizio Cassader
Journal:  Diabetes Care       Date:  2007-12-04       Impact factor: 19.112

2.  Glomerular filtration rate, cardiovascular risk factors and insulin resistance.

Authors:  Martín R Salazar; Horacio A Carbajal; Alberto G Marillet; Delfina M Gallo; María L Valli; Miguel Novello; Raúl F Echeverría
Journal:  Medicina (B Aires)       Date:  2009       Impact factor: 0.653

3.  Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of incident diagnosed diabetes in the Canary Islands.

Authors:  A Cabrera de León; S Domínguez Coello; D Almeida González; B Brito Díaz; J C del Castillo Rodríguez; A González Hernández; A Aguirre-Jaime; M del Cristo Rodríguez Pérez
Journal:  Diabet Med       Date:  2012-03       Impact factor: 4.359

4.  Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease.

Authors:  J Yip; F S Facchini; G M Reaven
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

5.  Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin resistance.

Authors:  Justo Sierra-Johnson; Bruce D Johnson; Thomas G Allison; Kent R Bailey; Gary L Schwartz; Stephen T Turner
Journal:  Diabetes Care       Date:  2006-03       Impact factor: 19.112

6.  Insulin resistance as a predictor of age-related diseases.

Authors:  F S Facchini; N Hua; F Abbasi; G M Reaven
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

7.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

8.  The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Vera Bittner; B Delia Johnson; Issam Zineh; William J Rogers; Diane Vido; Oscar C Marroquin; C Noel Bairey-Merz; George Sopko
Journal:  Am Heart J       Date:  2009-03       Impact factor: 4.749

9.  Use of metabolic markers to identify overweight individuals who are insulin resistant.

Authors:  Tracey McLaughlin; Fahim Abbasi; Karen Cheal; James Chu; Cindy Lamendola; Gerald Reaven
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391

10.  Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia.

Authors:  Youlian Liao; Soonho Kwon; Sara Shaughnessy; Penny Wallace; Amy Hutto; Alicia J Jenkins; Richard L Klein; W Timothy Garvey
Journal:  Diabetes Care       Date:  2004-04       Impact factor: 19.112

View more
  18 in total

1.  Associations between adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and biomarkers of inflammation, hormonal, and insulin response.

Authors:  Fred K Tabung; Teresa T Fung; Jorge E Chavarro; Stephanie A Smith-Warner; Walter C Willett; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2016-11-14       Impact factor: 7.396

2.  Use of the triglyceride to HDL cholesterol ratio for assessing insulin sensitivity in overweight and obese children in rural Appalachia.

Authors:  Kristie Grove Bridges; Traci Jarrett; Anthony Thorpe; Adam Baus; Jill Cochran
Journal:  J Pediatr Endocrinol Metab       Date:  2016-02       Impact factor: 1.634

3.  Triglyceride to high density lipoprotein cholesterol ratio and its association with periodontal disease in Korean adults: findings based on the 2012-2014 Korean national health and nutrition examination survey.

Authors:  Yu-Jin Kwon; Jeong-Won Park; Hyoung-Ji Lim; Yong-Jae Lee; Hye-Sun Lee; Jae-Yong Shim
Journal:  Clin Oral Investig       Date:  2017-06-06       Impact factor: 3.573

Review 4.  Associations of cadmium exposure with risk of metabolic syndrome and its individual components: a meta-analysis.

Authors:  Liping Lu; Yuexia Li; Cheng Chen; Yijia Zhang; Wenzhi Guo; Shuijun Zhang; Ka Kahe
Journal:  J Expo Sci Environ Epidemiol       Date:  2022-05-18       Impact factor: 5.563

5.  Development and validation of empirical indices to assess the insulinaemic potential of diet and lifestyle.

Authors:  Fred K Tabung; Weike Wang; Teresa T Fung; Frank B Hu; Stephanie A Smith-Warner; Jorge E Chavarro; Charles S Fuchs; Walter C Willett; Edward L Giovannucci
Journal:  Br J Nutr       Date:  2016-11-08       Impact factor: 3.718

Review 6.  The Natural Course of Impaired Fasting Glucose.

Authors:  Agnieszka Święcicka-Klama; Katarzyna Połtyn-Zaradna; Andrzej Szuba; Katarzyna Zatońska
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Lipoprotein heterogeneity may help to detect individuals with insulin resistance.

Authors:  Carlos Lorenzo; Anthony J Hanley; Marian J Rewers; Andreas Festa; Steven M Haffner
Journal:  Diabetologia       Date:  2015-09-04       Impact factor: 10.122

8.  TG/HDL-C RATIO AS CARDIO-METABOLIC BIOMARKER EVEN IN NORMAL WEIGHT WOMEN.

Authors:  G Borrayo; L Basurto; E González-Escudero; A Diaz; A Vázquez; L Sánchez; G O Hernández-González; S Barrera; J A Degollado; N Córdova; F Avelar
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Apr-Jun       Impact factor: 0.877

9.  Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.

Authors:  Luca A Lotta; Pawan Gulati; Felix R Day; Felicity Payne; Halit Ongen; Martijn van de Bunt; Kyle J Gaulton; John D Eicher; Stephen J Sharp; Jian'an Luan; Emanuella De Lucia Rolfe; Isobel D Stewart; Eleanor Wheeler; Sara M Willems; Claire Adams; Hanieh Yaghootkar; Nita G Forouhi; Kay-Tee Khaw; Andrew D Johnson; Robert K Semple; Timothy Frayling; John R B Perry; Emmanouil Dermitzakis; Mark I McCarthy; Inês Barroso; Nicholas J Wareham; David B Savage; Claudia Langenberg; Stephen O'Rahilly; Robert A Scott
Journal:  Nat Genet       Date:  2016-11-14       Impact factor: 38.330

10.  The Role of Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio to Predict New Cardiovascular Events in Essential Hypertensive Patients.

Authors:  Osman Turak; Barış Afşar; Fırat Ozcan; Fatih Öksüz; Mehmet Ali Mendi; Çagrı Yayla; Adrian Covic; Nathan Bertelsen; Mehmet Kanbay
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-22       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.